Skip to main content

Table 1 Clinical features of patients infected with HAdV-55 or HAdV-7 in this study

From: Case-control study of the epidemiological and clinical features of human adenovirus 55 and human adenovirus 7 infection in children with acute lower respiratory tract infections in Beijing, China, 2008–2013

  HAdV55 (n = 8) HAdV7 (n = 32) P
Age (yrs) 0.73 ± 0.78 2.48 ± 3.06 0.120
Male (%) 5/8 (63%) 26/32 (81%) 0.256
Any underlying diseases 0 2/32 0.529
Symptoms and signs
 Fever≥38 °C 7/7 a (100%) 32/32 (100%) /
 Maximum temperature (°C) 39.41 ± 0.94b 39.79 ± 0.64 0.161
 Duration of fever (days) 14.5 ± 10.75b 15.14 ± 5.48 0.960
 Cough 6/6b (100%) 32/32 (100%) /
 Rhinorrhea 2/6b (33%) 4/32 (13%) 0.199
 Wheezing 1/6b (17%) 20/32 (63%) 0.038c
 Swelling of tonsils 4/6b (67%) 13/32 (41%) 0.239
 Rash 2/6b (33%) 5/32 (16%) 0.305
 Vomiting 0b 3/32 (9%) 0.435
 Diarrhea 1/6b (17%) 11/32 (34%) 0.392
 Dyspnea 2/6b (33%) 10/32 (31%) 0.920
 Lung infiltrates 4/6b (67%) 16/32 (50%) 0.453
 Complicationd 2/7a (29%) 18/32 (56%) 0.184
Laboratory detection
 WBC (109/L) 11.48 ± 3.08a 10.64 ± 5.71 0.709
 Neutrophil % 63.20% ± 15.03%a 57.98% ± 17.46% 0.469
 Lymphocyte % 29.26% ± 12.53%a 35.25% ± 17.59% 0.402
 Platelet (109/L) 274.71 ± 184.61a 291.29 ± 146.87 0.801
 CRP (mg/L) 26.53 ± 24.84a 33.42 ± 45.86 0.706
Treatment
 ICU admission 1/7a (14%) 5/32 (16%) 0.929
 Mechanical ventilation 1/6b (17%) 9/32 (28%) 0.559
 Immunoglobulin 2/7a (29%) 17/32 (53%) 0.239
 Length of hospital stay (days) 11.33 ± 6.86b 19.10 ± 10.41 0.109
 Clinical scoree 6.43 ± 2.44a 8.21 ± 2.98 0.148
  1. Note:
  2. aOne subject was an outpatient, and information about this subject was not documented
  3. bThere was a patient (other than the aforementioned outpatient) who left hospital in advance and without recovery, and her clinical features (except for the first blood test after admission to hospital) could not be documented
  4. cStatistically significant (P < 0.05)
  5. dComplications include respiratory failure, cardiac damage, or liver function damage
  6. eA clinical scoring system for ALRTIs was used to assess severity of illness on the day of enrollment